Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7753418 | 0.76 | ALDH1A1 (0.46) | ALDH1A1TRPA1LMNA | |
| SCHEMBL15323825 | 0.72 | ALDH1A1 (0.37) | ALDH1A1LMNA | |
| SCHEMBL20793424 | 0.71 | TDP1 (0.42) | ALDH1A1TRPA1LMNA | |
| SCHEMBL24377667 | 0.71 | PRKCA (0.38) | — | |
| SCHEMBL15323710 | 0.71 | LMNA (0.46) | ALDH1A1LMNA | |
| SCHEMBL10977328 | 0.71 | PRKCA (0.42) | ALDH1A1LMNA | |
| SCHEMBL26011222 | 0.69 | CTSK (0.31) | ALDH1A1LMNA | |
| SCHEMBL2633186 | 0.69 | — | — | |
| SCHEMBL9298460 | 0.69 | TRPA1 (0.48) | ALDH1A1TRPA1LMNA | |
| SCHEMBL19300632 | 0.68 | ALDH1A1 (0.36) | ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070190128-A1 | Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070190128-A1 | Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds | CRAT, SLC25A20, CPT1B | ALDH1A1 637/4885TRPA1 1879/4885LMNA 238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.